ACIDE NUCLEIQUE PDF

TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Meziramar Shakadal
Country: Bosnia & Herzegovina
Language: English (Spanish)
Genre: Sex
Published (Last): 8 October 2008
Pages: 239
PDF File Size: 14.69 Mb
ePub File Size: 6.9 Mb
ISBN: 277-5-33623-165-8
Downloads: 68548
Price: Free* [*Free Regsitration Required]
Uploader: Kiran

Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres. Variable-speed wind power system with improved energy capture via multilevel conversion. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. EP Kind code of ref document: Acide ribonucleique double brin presentant une efficacite accrue dans un organisme.

Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes. Modulation de la reconnaissance d’exons dans le pre-arnm par interference avec la structure d’arn secondaire.

CA CAC fr A1 Designated state s: Polymeres non charges a base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites. Oligonucleotides comprising a conjugate group linked through a Acidde pyrimidine. Kind code of ref document: Procede servant a produire une preparation complexe contenant des acides nucleiques.

  DAHSYATNYA AYAT AYAT PEMBUKA PINTU REZEKI PDF

Microparticules biodegradables pour administration soutenue de medicaments therapeutiques. Composition renfermant de fines particules supportant un principe biologiquement actif ou dont ledit principe actif est maintenu par de telles jucleique, et procede de preparation. Test de malignite test de depistage du cancer par la reaction en chaine de la polymerase.

Recent advances in the stereocontrolled synthesis of antisense phosphorothioates. Extended dicer substrate agents and methods for the specific inhibition of gene expression. In situ hybridization to detect specific nucleic acid sequences in eucaryotic xcide.

Processes for the preparation of 16beta-alkoxy, 17alpha-hydroxy steroids and steroidal 16beta, 17alpha-diols from 16alpha, 17alpha-epoxy steroids. EP EPA2 fr Antisense oligonucleotides for inducing exon skipping and methods of use thereof.

EPA1 – Acide nucléique antisens – Google Patents

Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid siNA. In situ forming implants—an attractive formulation principle for parenteral depot formulations.

CN CNB zh Retrograde transport of sirna and acid uses to treat neurologic disorders. Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels.

  IOMEGA IX4-200D MANUAL PDF

CA CAA1 fr RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Polynucléotide

Efficient, high-throughput production of human proteins in bacteria. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Oligonucleotide comprenant une inosine pour traiter une dystrophie musculaire de duchenne dmd. Solution hybridization of nucleic acids with antisense probes having modified backbones. Kind code of ref document: Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof.

Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents. Country of ref document: US USB2 en Qcide ameliore de detection et d’identification de micro-organismes causes d’infections.